Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
48 hedge funds and large institutions have $120M invested in Tobira Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
91% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 11
69% more capital invested
Capital invested by funds: $70.9M → $120M (+$48.7M)
2% less funds holding
Funds holding: 49 → 48 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$7.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.71M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.12M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$812K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.34M |
| 2 |
Morgan Stanley
New York
|
-$1.02M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$348K |
| 4 |
Goldman Sachs
New York
|
-$278K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
-$145K |
TBRA Hedge Fund Activity: Q4 2015 in Review
48 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q4 2015, worth a combined $120M — up 69% from $70.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TBRA and 6 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 21 added.
The largest buyer was Sabby Management, adding an estimated $7.3M. The largest seller was Novo Holdings A/S, cutting an estimated $2.34M.
- 48 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q4 2015, down from 49 in Q3 2015.
- Funds reported $120M of Tobira Therapeutics, Inc. Common Stock stock for Q4 2015, up 69% quarter-over-quarter.
- 6 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q4 2015 and 7 closed out, a net change of -1 holder.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q4 2015 was Sabby Management, an estimated $7.3M added.
- The largest Tobira Therapeutics, Inc. Common Stock seller in Q4 2015 was Novo Holdings A/S, an estimated $2.34M sold.
Based on aggregated 13F filings for Q4 2015.